Viral vector manufacturing market was valued at USD 254.54 million in 2018, at a CAGR of 9.2% during the forecast period 2019-2026.
Increasing prevalence of chronic diseases and targeted diseases are driving the demand for gene therapy. During viral vector transmission, it is ensured that the viral particle is not infectious. Today, retrovirus adenovirus, adeno-associated virus, and lentivirus are most commonly used as a ... Read more
